Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver J D Hatley

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biopharmaceutics & Drug Disposition|January 1, 2017
Quantifying gut wall metabolism: methodology mattersOliver J D Hatley, Christopher R Jones, Aleksandra Galetin, et al.
Biopharmaceutics & Drug Disposition|February 17, 2017
Optimization of intestinal microsomal preparation in the rat: A systematic approach to assess the influence of various methodologies on metabolic activity and scaling factorsOliver J D Hatley, Christopher R Jones, Aleksandra Galetin, et al.
Clinical Pharmacokinetics|February 20, 2016
Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical ModelsSheila Annie Peters, Christopher R Jones, Anna-Lena Ungell, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 31, 2013
Animal versus human oral drug bioavailability: do they correlate?Helen Musther, Andrés Olivares-Morales, Oliver J D Hatley, et al.
Pharmaceutical Research|September 28, 2013
The use of ROC analysis for the qualitative prediction of human oral bioavailability from animal dataAndrés Olivares-Morales, Oliver J D Hatley, David Turner, et al.
The AAPS Journal|March 12, 2016
Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass EliminationChristopher R Jones, Oliver J D Hatley, Anna-Lena Ungell, et al.
Pharmaceutical Research|July 19, 2014
Quantitative ADME proteomics - CYP and UGT enzymes in the Beagle dog liver and intestineAki T Heikkinen, Arno Friedlein, Mariette Matondo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biopharmaceutics & Drug Disposition|January 1, 2017
Quantifying gut wall metabolism: methodology mattersOliver J D Hatley, Christopher R Jones, Aleksandra Galetin, et al.
Biopharmaceutics & Drug Disposition|February 17, 2017
Optimization of intestinal microsomal preparation in the rat: A systematic approach to assess the influence of various methodologies on metabolic activity and scaling factorsOliver J D Hatley, Christopher R Jones, Aleksandra Galetin, et al.
Clinical Pharmacokinetics|February 20, 2016
Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical ModelsSheila Annie Peters, Christopher R Jones, Anna-Lena Ungell, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 31, 2013
Animal versus human oral drug bioavailability: do they correlate?Helen Musther, Andrés Olivares-Morales, Oliver J D Hatley, et al.
Pharmaceutical Research|September 28, 2013
The use of ROC analysis for the qualitative prediction of human oral bioavailability from animal dataAndrés Olivares-Morales, Oliver J D Hatley, David Turner, et al.
The AAPS Journal|March 12, 2016
Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass EliminationChristopher R Jones, Oliver J D Hatley, Anna-Lena Ungell, et al.
Pharmaceutical Research|July 19, 2014
Quantitative ADME proteomics - CYP and UGT enzymes in the Beagle dog liver and intestineAki T Heikkinen, Arno Friedlein, Mariette Matondo, et al.
Pageof 1